Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP, Glob. Prod. Dev. & Supply

President, Cell Therapy Org.

EVP, Chief Financial Officer

EVP,Chief Med.Offr.,Drug Dev.

Executive Chair of the Board

EVP, Chief Research Officer

EVP, Corporate Affairs

EVP, General Counsel

SVP and Controller

EVP, Chief Human Resources

Chief Executive Officer

EVP, Chief Commercial Officer

EVP, Chief Digital & Tech Off.

Board Chair and CEO

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; Orencia for adult patients with active RA and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Onureg for the treatment of adult patients with AML; Inrebic, an oral kinase inhibitor indicated for the treatment of myelofibrosis; Camzyos for the treatment of adults with symptomatic obstructive HCM to enhance functional capacity and symptoms; Sotyktu for the treatment of adults with moderate-to-severe plaque psoriasis; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane, a protein-bound chemotherapy product. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products world...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-01	Premium	acquired	Premium	Premium	Premium	EVP, Glob. Prod. Dev. & Supply
2024-04-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Glob. Prod. Dev. & Supply
2024-03-10	Premium	acquired	Premium	Premium	Premium	President, Cell Therapy Org.
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, Chief Financial Officer
2024-03-10	Premium	sold	Premium	Premium	Premium	EVP,Chief Med.Offr.,Drug Dev.
2024-03-10	Premium	sold	Premium	Premium	Premium	Executive Chair of the Board
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	President, Cell Therapy Org.
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Research Officer
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Corporate Affairs
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, General Counsel
2024-03-10	Premium	sold	Premium	Premium	Premium	EVP, General Counsel
2024-03-10	Premium	sold	Premium	Premium	Premium	SVP and Controller
2024-03-10	Premium	sold	Premium	Premium	Premium	EVP, Chief Financial Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, Chief Research Officer
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Human Resources
2024-03-10	Premium	sold	Premium	Premium	Premium	EVP, Corporate Affairs
2024-03-10	Premium	acquired	Premium	Premium	Premium	Executive Chair of the Board
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Financial Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP,Chief Med.Offr.,Drug Dev.
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-03-10	Premium	sold	Premium	Premium	Premium	President, Cell Therapy Org.
2024-03-10	Premium	sold	Premium	Premium	Premium	EVP, Chief Human Resources
2024-03-10	Premium	sold	Premium	Premium	Premium	EVP, Chief Research Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, Corporate Affairs
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP,Chief Med.Offr.,Drug Dev.

BMY - Bristol-Myers Squibb Co Stock Price, Fair Value and News

Latest Insider Trading transactions for BMY